RFP, CGN and CGA Opportunities
The Alliance is a community dedicated to accelerating excellence in healthcare performance through education and collaboration. To help achieve this, we collect information on research proposals and grants offered through other healthcare-related organizations.
- American Academy of Dermatology
- Bristol-Myers Squibb
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Sanofi US Medical Affairs
- Spark Therapeutics
The intent of this Call for Grant Application (CGA) in Infectious Disease – Fungal is to encourage organizations to submit grant applications for accredited independent education designed to close education gaps identified in the public healthcare landscape, drive measureable improvements in competence and performance of healthcare professionals, and advance patient health outcomes. All applications must be submitted online by October 13, 2017 through the Astellas Grant Management System, accessible at www.astellasgrants.com.
American Academy of Dermatology
The Academy bestows a number of prestigious awards to recognize the contributions of individuals to the specialty as well as offering various grants and scholarships to assist recipients in furthering their areas of study and broadening knowledge in the field of dermatology.
Program for Innovative Continuing Medical Education in Dermatology (PICMED)
The program was established to facilitate dermatologists' continuing education through support and development of innovative continuing medical education programs.
- Multi-year grant: Applicants may request up to $50,000 (direct costs only) for a two (2) year funding period. 2nd year funding will be contingent on 1st year milestones being met.
- Single-year grant: Applicants may request up to $10,000 (direct costs only) for a one (1) year project period.
Bristol-Myers Squibb accepts funding requests within the following therapeutic areas of interest. As areas of interest and funding consideration may change periodically, please consult this website frequently. Please note that international funding opportunities may differ.
- Genetically Defined / Rare Diseases
Boehringer Ingelheim Pharmaceuticals, Inc.
The intent of this Request for Educational Grant Applications (REGA) announcement is to notify experienced and eligible medical education providers that BIPI is interested in receiving applications for IME activities pertinent to Mesothelioma and aligned to the specifications outlined in the downloadable Request for Proposal.
Therapeutic Area: Oncology- Mesothelioma
REGA Submission Deadline: Accepted on an ongoing basis. Review is prioritized based on date of receipt, program requirements and available budget.
Sanofi US Medical Affairs
Sanofi US is committed to funding high quality educational activities and materials in the therapeutic areas of interest to the company that have the potential to improve patient care and health outcomes.
The purpose of an educational grant is to support an activity that encourages an educational interchange with respect to available scientific and medical information. Educational activities may or may not be accredited.
Therapeutic Area: Diabetes
Educational Grant Portal for submissions: https://sgrants.envisionpharma.com/vt_sgrants/
Area of Interest: Type 1 DM: New and Emerging Therapeutic Strategies for Adults
Submission Deadline: October 30, 2017 at 5:00 pm EST
Download Request for Proposal
Spark Therapeutics invites proposals for inventive educational initiatives that focus on appropriate genetic testing and diagnosis of patients with inherited retinal diseases.
Submission deadline: 11:59 pm PT on September 22, 2017. Late submissions or incomplete proposals will not be reviewed.
Complete proposal applications should be sent to Spark Therapeutics via email to email@example.com with RFP Reference: RFP: IRD2017-01 in the email title.